Red-shifted bioluminescent emitters allow improved in vivo tissue penetration and signal quantification, and have led to the development of beetle luciferin analogues that elicit red-shifted bioluminescence with firefly luciferase (Fluc). However, unlike natural luciferin, none have been shown to emit different colors with different luciferases. We have synthesized and tested the first dual-color, far-red to nearinfrared (nIR) emitting analogue of beetle luciferin, which, akin to natural luciferin, exhibits pH dependent fluorescence spectra and emits bioluminescence of different colors with different engineered Fluc enzymes. Our analogue produces different far-red to nIR emission maxima up to l max = 706 nm with different Fluc mutants. This emission is the most redshifted bioluminescence reported without using a resonance energy transfer acceptor. This improvement should allow tissues to be more effectively probed using multiparametric deep-tissue bioluminescence imaging.Bioluminescence imaging (BLI) has revolutionized molecular genetic imaging in biomedical research as a cheap and easy means to longitudinally image the genetic behavior of life and disease processes in whole mammals. [1][2][3][4] As they produce the brightest form of bioluminescence, [5] genes from coleopterans are commonly used to localize, track, and quantify cells and molecular or functional events in vivo. [6][7][8] In a well-studied reaction, [9] beetle luciferin (1, Figure 1 a) is adenylated by firefly luciferase (Fluc) and this reacts with molecular oxygen to produce an excited state species, oxyluciferin* (2), which decays to release a photon with a high quantum yield (l max = 558 nm).[5] However, absorption of visible light by hemoglobin (Hb) and melanin restricts image resolution and signal penetration at this wavelength. Between l = 600-800 nm, the absorption of light by Hb decreases by a factor of approximately 50, resulting in less attenuation of red light. This wavelength range is within what is termed the "bio-optical window" and there has been much focus on engineering red-shifted Fluc enzymes that have maximum emission wavelengths in this range, [10][11][12][13][14][15] but these have peaked at wavelengths less than l = 645 nm.The most red-shifted luciferin analogues to date [16] are based upon amino derivatives (Figure 1 b), for example cyclic aminoluciferin (3 a: l max = 599 nm; 3 b: l max = 607 nm), [17] seleno-d-aminoluciferin (4: l max = 600 nm), [18] and a rationally designed 4-(dimethylamino)phenyl derivative conjugated to a thiazoline group (5: l max = 675 nm). [19] In particular cyclic aminoluciferin derivative 3 a has been shown to give improved bioluminescence imaging compared to luciferin (LH 2 ; 1) at dilute concentrations where the intracellular concentration of the luciferin or analogue is limiting.[20] Nearinfrared emission has been detected with an aminoluciferin Cy5 conjugate, but this is due to bioluminescence resonance energy transfer (BRET), [21] meaning that the conjugate cannot be used for multip...